Covid-19 roundup: CDC study shows good protection from mRNA booster plus J&J's single-dose vaccine; White House launches test-to-treat Paxlovid site
Concerns about rare but life-threatening blood clots have limited the use of J&J’s Covid-19 vaccine — once pitched as the only one-shot option in the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
